Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India

Published:2017-12 Issue:12 Volume:19 Page:693-698
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Misra Anoop¹²³,Mukherjee Rupali⁴,Luthra Atul³,Singh Padam³

Affiliation:

1. National Diabetes, Obesity and Cholesterol Foundation (N-DOC), SDA, New Delhi, India.

2. Diabetes Foundation (India), SDA, New Delhi, India.

3. Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, New Delhi, India.

4. Times of India, Mumbai, India.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2017.0286

Reference16 articles.

1. Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions

2. Diabetes in South Asians

3. Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014

4. Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan

5. Availability of medicines in public sector health facilities of two North Indian States

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of diabetes and its complications: results from a STEPS survey in Punjab, India;Global Health Research and Policy;2023-04-07

2. A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda;Journal of the Indian Institute of Science;2023-01

3. Rising cost of insulin: A deterrent to compliance in patients with diabetes mellitus;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-08

4. Effect of comorbidities on direct cost among type 2 diabetes mellitus (T2DM) patients in tertiary care government hospital in Uttarakhand, India: A primary data analysis of out of pocket expenditure;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2020-11

5. Injectable combination therapies for the management of diabetes: an Indian perspective;Expert Opinion on Drug Metabolism & Toxicology;2020-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3